NewsBenzingaUBS rebaja la recomendación de Ormat Technologies a neutral y reduce el precio objetivo a 100 dólares. UBS rebaja la recomendación de Ormat Technologies a neutral y reduce el precio objetivo a 100 dólares. Benzinga 2026.10.01 14:17 (GMT+0) Open on Benzinga Other news 'OpenAI Parts Ways With Researchers Who Allegedly Shared Confidential Information'- WSJ Exclusive Interactive Brokers Reports 4.111M Daily Average Revenue Trades In September, Up 6% YoY Foghorn Therapeutics Pivots Pipeline after Ending Eli Lilly Deal Mizuho Maintains Outperform on Micron Technology, Raises Price Target to $1400 Reported Earlier, Enerflex Awarded Contract To Design, Engineer, Fabricate And Assemble ~450 MW Of Behind-The-Meter Natural Gas Power Generation Units For A North American Data Center Developer; Terms Not Disclosed Here's How Much $100 Invested In Alnylam Pharmaceuticals 20 Years Ago Would Be Worth Today
Reported Earlier, Enerflex Awarded Contract To Design, Engineer, Fabricate And Assemble ~450 MW Of Behind-The-Meter Natural Gas Power Generation Units For A North American Data Center Developer; Terms Not Disclosed
